https://www.selleckchem.com/products/ml324.html
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-218 promotes apoptosis of U2OS osteosarcoma cells through targeting BIRC5, by D.-Z. Wang, S.-F. Jing, S.-B. Hao, X.-Y. Huang, Q.-T. Miao, J.-F. Gao, published in Eur Rev Med Pharmacol Sci 2018; 22(2 6650-6657-DOI 10.26355/eurrev_201810_16140-PMID 30402837" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https//www.europeanreview.org/art
Like
Comment
Share
